|
Studying Viral Hepatitis B Stigma using the ALLIES Approach: A Mixed Methods Design
|
|
8
|
247
|
31 2024
|
|
Strategies to prevent vertical transmission amongst children: lessons from nigeria
|
|
1
|
162
|
31 2024
|
|
Mothers Living with Hepatitis B - A Needs and Assets Assessment
|
|
3
|
222
|
31 2024
|
|
Is Cure coming in future?
|
|
84
|
9408
|
22 2024
|
|
2024 Research showcase
|
|
2
|
216
|
28 2024
|
|
Brain storm, Idea to treat HBV, ain't no expert
|
|
3
|
285
|
10 2024
|
|
cccDNA destabiliser as a new therapy for HBV cure
|
|
12
|
1147
|
4 2024
|
|
CAMs mode of action informatio ln
|
|
12
|
991
|
23 2024
|
|
Looking ahead-2023
|
|
23
|
2013
|
12 2024
|
|
HepB and testostorone level
|
|
2
|
472
|
28 2024
|
|
New approved drugs for patients with fatty liver disease
|
|
1
|
312
|
29 2024
|
|
Possible cure for HIV, probably also HepB ? CRISP
|
|
2
|
387
|
26 2024
|
|
EXAMPLE ENTRY: Integrated HBV DNA: a hidden contributor to liver cancer and virus persistence?
|
|
4
|
477
|
30 2023
|
|
Antivirals indirectly reduce integrated DNA?
|
|
7
|
551
|
2 2024
|
|
Prolactinoma and chronic Hepatitis B infection
|
|
1
|
192
|
19 2024
|
|
Nucleic acid polymers (NAPs): targeting subviral particles to achieve HBV functional cure
|
|
177
|
5109
|
18 2024
|
|
CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virus
|
|
1
|
291
|
24 January 2024
|
|
Why do we need a Hepatitis B cure? What are the benefits for patients? - HBV Cure FAQs
|
|
1
|
967
|
14 2022
|
|
The Hepatitis B polymerase: A difficult problem begins to crack
|
|
12
|
1615
|
31 January 2024
|
|
Iron ferritin levels with hep b
|
|
9
|
878
|
1 2023
|
|
Example entry: Hepatitis B cccDNA viral reservoirs - stubborn nails in the quest for a complete cure
|
|
14
|
971
|
31 January 2024
|
|
Targeting TM6SF2 to Reduce HBV Subviral Particles: A Potential Step Towards a Functional Cure
|
|
6
|
1425
|
31 January 2024
|
|
HBV cure what’s the latest information
|
|
1
|
1049
|
13 2023
|
|
Deadline Extension: Research Showcase 2023
|
|
5
|
625
|
26 2023
|
|
Understanding Hepatitis B and Liver Cancer Knowledge and Testing Among Different Communities
|
|
3
|
477
|
31 January 2024
|
|
The EMPOWER-B study – predicting Hepatitis B cure or relapse after treatment cessation
|
|
2
|
529
|
31 January 2024
|
|
CRISPR-Cas13b: A potential new treatment for HBV
|
|
1
|
478
|
31 January 2024
|
|
Host protein complex shuts down cccDNA: An interesting way of viral suppression
|
|
2
|
508
|
31 January 2024
|
|
Lived experiences of chronic hepatitis B in relation to stigma and discrimination among Chinese immigrants in Australia
|
|
5
|
482
|
31 January 2024
|
|
Physical, Social, and Emotional Impacts of Living with Hepatitis B: Implications for Clinical Care and Drug Development
|
|
6
|
437
|
31 January 2024
|